Eterna Therapeutics - ERNA Revenue Change YoY (Last 12 Months)

Graphic logo of eternatx.com (ERNA)

The complexity of cellular engineering and patent disputes are creating volatility within the sector. The year-over-year dynamics of commercial revenues on a rolling basis demonstrate current fluctuations, where -99.80 serves as the final level mark. Stable mRNA supply chains and innovative developments in oncology provide Eterna Therapeutics (ERNA) with growth potential and high product relevance by 2026.

Eterna Therapeutics (ERNA) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/18/2026

Eterna Therapeutics, Inc. (ERNA) - metric breakdowns and financial figures

- market value and analyst target forecast:
Fundamental company valuation:Eterna Therapeutics, Inc.
Flagship merchandise of Eterna Therapeutics Inc.

This indicator calculates the percentage change in revenue over the last twelve months relative to the same period last year, identifying real-time demand dynamics. For Eterna Therapeutics (ERNA), whose value is based on mRNA editing, the LTM annual sales growth rate serves as a marker for technology commercialization and confirms a fundamental business pivot amid ongoing clinical trials.